BIOCRYST PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 3,690 | $5.08 | $18,745 | 15,130 | Dec 1, 2017 |
| Sheridan William P | Senior VP - CMO | Sale | 64,310 | $4.72 | $303,543 | 23,855 | Nov 13, 2017 |
| Cohen Fred E | — | Sale | 54,250 | $5.42 | $294,035 | 119,410 | Sep 18, 2017 |
| Hutson Nancy J | — | Award / Grant | 1,960 | $5.10 | $9,996 | 34,167 | Sep 1, 2017 |
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 3,676 | $5.10 | $18,748 | 11,440 | Sep 1, 2017 |
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 1,941 | $5.15 | $9,996 | 7,764 | Jun 1, 2017 |
| Cohen Fred E | — | Award / Grant | 1,941 | $5.15 | $9,996 | 119,410 | Jun 1, 2017 |
| Hutson Nancy J | — | Award / Grant | 1,941 | $5.15 | $9,996 | 32,207 | Jun 1, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 7,750 | $4.73 | $36,658 | 149,210 | May 22, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,250 | $9.20 | $29,900 | 141,460 | Mar 20, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 12,308 | $8.80 | $108,310 | 141,460 | Mar 16, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,250 | $9.06 | $29,445 | 117,313 | Mar 10, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,250 | $8.65 | $28,113 | 117,313 | Mar 8, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 3,250 | $7.90 | $25,675 | 117,313 | Mar 6, 2017 |
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 1,602 | $6.24 | $9,996 | 5,823 | Mar 2, 2017 |
| Hutson Nancy J | — | Award / Grant | 1,602 | $6.24 | $9,996 | 30,266 | Mar 1, 2017 |
| Cohen Fred E | — | Award / Grant | 1,602 | $6.24 | $9,996 | 117,469 | Mar 1, 2017 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Tax Withholding | 2,599 | $5.95 | $15,464 | 75,497 | Jan 20, 2017 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Tax Withholding | 5,083 | $5.95 | $30,244 | 104,706 | Jan 20, 2017 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 5,761 | $5.95 | $34,278 | 82,916 | Jan 20, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 5,198 | $5.95 | $30,928 | 117,313 | Jan 20, 2017 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 10,572 | $5.95 | $62,903 | 645,418 | Jan 20, 2017 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 2,081 | $6.33 | $13,173 | 88,677 | Jan 1, 2017 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Tax Withholding | 1,639 | $6.33 | $10,375 | 109,789 | Jan 1, 2017 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 8,595 | $6.33 | $54,406 | 655,990 | Jan 1, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 1,676 | $6.33 | $10,609 | 122,511 | Jan 1, 2017 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Tax Withholding | 1,281 | $6.33 | $8,109 | 78,096 | Jan 1, 2017 |
| STAAB THOMAS R II | Senior Vice President and CFO | Option Exercise | 3,250 | $3.78 | $12,285 | 127,437 | Dec 19, 2016 |
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 1,788 | $5.59 | $9,995 | 4,221 | Dec 1, 2016 |
| Hutson Nancy J | — | Award / Grant | 1,788 | $5.59 | $9,995 | 28,664 | Dec 1, 2016 |
| Cohen Fred E | — | Award / Grant | 1,788 | $5.59 | $9,995 | 115,867 | Dec 1, 2016 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Sale | 8,357 | $4.27 | $35,684 | 79,377 | Sep 14, 2016 |
| Hutson Nancy J | — | Award / Grant | 2,433 | $4.11 | $10,000 | 26,876 | Sep 1, 2016 |
| Cohen Fred E | — | Award / Grant | 2,433 | $4.11 | $10,000 | 114,079 | Sep 1, 2016 |
| INGRAM ROBERT ALEXANDER | — | Award / Grant | 2,433 | $4.11 | $10,000 | 2,433 | Sep 1, 2016 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Sale | 30,000 | $4.06 | $121,800 | 111,428 | Aug 25, 2016 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 1,306 | $5.05 | $6,595 | 128,745 | Aug 12, 2016 |
| BAKER JULIAN | — | Sale | 296,856 | $5.25 | $1,558,494 | 9,762,823 | Aug 12, 2016 |
| STAAB THOMAS R II | Senior Vice President and CFO | Sale | 14,577 | $4.43 | $64,576 | 130,051 | Aug 9, 2016 |
| Hutson Nancy J | — | Award / Grant | 2,581 | $3.39 | $8,750 | 24,443 | May 31, 2016 |
| Cohen Fred E | — | Award / Grant | 2,581 | $3.39 | $8,750 | 111,646 | May 31, 2016 |
| Barnes Alane P | VP, General Counsel & Corp Sec | Tax Withholding | 687 | $2.13 | $1,463 | 85,416 | Mar 1, 2016 |
| Stonehouse Jon P | President & CEO | Tax Withholding | 2,761 | $2.13 | $5,881 | 664,585 | Mar 1, 2016 |
| STAAB THOMAS R II | Senior Vice President and CFO | Tax Withholding | 465 | $2.13 | $990 | 144,628 | Mar 1, 2016 |
| Sheridan William P | Senior VP - CMO | Tax Withholding | 799 | $2.13 | $1,702 | 90,052 | Mar 1, 2016 |
| Babu Yarlagadda S | Senior VP - Drug Discovery | Tax Withholding | 906 | $2.13 | $1,930 | 141,428 | Mar 1, 2016 |
| SANDERS CHARLES A | — | Award / Grant | 4,396 | $1.99 | $8,748 | 12,971 | Feb 29, 2016 |
| Cohen Fred E | — | Award / Grant | 4,396 | $1.99 | $8,748 | 109,065 | Feb 29, 2016 |
| Hutson Nancy J | — | Award / Grant | 4,396 | $1.99 | $8,748 | 21,862 | Feb 29, 2016 |
| BAKER FELIX | — | Purchase | 45,000 | $6.33 | $284,850 | 12,894,240 | Feb 5, 2016 |